Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03374085
Title A Safety, PK and Efficacy Study of CC-92480 in Combination With Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Celgene
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GRC | GBR | FIN | ESP | DNK | CAN | BEL | AUS

Facility Status City State Zip Country Details
Local Institution - 103 Duarte California 91010-300 United States Details
Local Institution - 102 Atlanta Georgia 30322 United States Details
Local Institution - 105 Boston Massachusetts 02115 United States Details
Local Institution - 111 Buffalo New York 14263 United States Details
Local Institution - 104 New York New York 10065 United States Details
Local Institution - 108 Spartanburg South Carolina 29303 United States Details
Local Institution - 101 Nashville Tennessee 37203 United States Details
Local Institution - 106 Houston Texas 77030 United States Details
Local Institution - 112 Charlottesville Virginia 22908 United States Details
Local Institution - 109 Seattle Washington 98104 United States Details
Local Institution - 804 Camperdown New South Wales 2050 Australia Details
Local Institution - 802 Adelaide South Australia 5000 Australia Details
Local Institution - 805 Clayton Victoria 3168 Australia Details
Local Institution - 803 Melbourne Victoria 3004 Australia Details
Local Institution - 806 Fitzroy 3065 Australia Details
Local Institution - 904 Antwerpen 2060 Belgium Details
Local Institution - 905 Gent 9000 Belgium Details
Local Institution - 901 Leuven 3000 Belgium Details
Local Institution - 902 Yvoir 5530 Belgium Details
Local Institution - 201 Calgary Alberta T2N 4N2 Canada Details
Local Institution - 204 London Ontario N6C 6B5 Canada Details
Local Institution - 205 Ottawa Ontario K1H 8L6 Canada Details
Local Institution - 202 Toronto Ontario M5G 2M9 Canada Details
Local Institution - 206 Montreal Quebec H4A 3J1 Canada Details
Local Institution - 203 Quebec G1R 2J6 Canada Details
Local Institution - 503 Aarhus N DK-8200 Denmark Details
Local Institution - 501 Copenhagen 2100 Denmark Details
Local Institution - 502 Odense 5000 Denmark Details
Local Institution - 601 Helsinki 00029 Finland Details
Local Institution - 001 Athens 11528 Greece Details
Local Institution - 705 Chuo-ku,chiba 260-8677 Japan Details
Local Institution - 703 Fukuoka 810-8563 Japan Details
Local Institution - 704 Kashiwa 277-8577 Japan Details
Local Institution - 702 Kobe-city 650-0047 Japan Details
Local Institution - 706 Kyoto-City 602-8566 Japan Details
Local Institution - 701 Okayama 701-1192 Japan Details
Local Institution - 152 Seoul 120-752 Korea, Republic of Details
Local Institution - 150 Seoul 135-710 Korea, Republic of Details
Local Institution - 151 Seoul 3080 Korea, Republic of Details
Local Institution - 403 Badalona (Barcelona) 08916 Spain Details
Local Institution - 407 Barcelona 08025 Spain Details
Local Institution - 406 Caceres 10003 Spain Details
Local Institution - 404 Madrid 28041 Spain Details
Local Institution - 401 Pamplona 31008 Spain Details
Local Institution - 409 Pozuelo de Alarcon 28223 Spain Details
Local Institution - 402 Salamanca 37007 Spain Details
Local Institution - 408 Santander 39008 Spain Details
Local Institution - 405 Valencia 46026 Spain Details
Local Institution - 304 Plymouth Devon PL6 8DH United Kingdom Details
Local Institution - 306 Cardiff CF14 4XW United Kingdom Details
Local Institution - 303 London NW1 2PG United Kingdom Details
Local Institution - 305 Newcastle Upon Tyne NE7 7DN United Kingdom Details
Local Institution - 302 Oxford OX3 7LE United Kingdom Details
Local Institution - 301 Sutton SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field